Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?
作者信息
Muscari Fabrice, Maulat Charlotte
机构信息
Department of Digestive Surgery and Transplantation, Toulouse University Hospital, Toulouse, France.
出版信息
Transl Gastroenterol Hepatol. 2020 Oct 5;5:46. doi: 10.21037/tgh.2019.12.09. eCollection 2020.
Abstract
摘要
相似文献
1
Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?肝细胞癌（HCC）术前甲胎蛋白（AFP）：这个50年的生物标志物仍与时俱进吗？
Transl Gastroenterol Hepatol. 2020 Oct 5;5:46. doi: 10.21037/tgh.2019.12.09. eCollection 2020.
2
Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.同型半胱氨酸：甲胎蛋白阴性肝细胞癌肝移植的新型预后生物标志物。
Cancer Biomark. 2020;29(2):197-206. doi: 10.3233/CBM-201545.
3
Alpha-fetoprotein still is a valuable diagnostic and prognosis predicting biomarker in hepatitis B virus infection-related hepatocellular carcinoma.甲胎蛋白仍然是乙型肝炎病毒感染相关肝细胞癌中一种有价值的诊断和预后预测生物标志物。
Oncotarget. 2016 Jan 26;7(4):3702-8. doi: 10.18632/oncotarget.6913.
4
Baseline Alpha-Fetoprotein, Alpha-Fetoprotein-L3, and Des-Gamma-Carboxy Prothrombin Biomarker Status in Bridge to Liver Transplant Outcomes for Hepatocellular Carcinoma.基线甲胎蛋白、甲胎蛋白-L3和去γ-羧基凝血酶原生物标志物状态在肝细胞癌肝移植桥接治疗结局中的作用
Cancers (Basel). 2021 Sep 23;13(19):4765. doi: 10.3390/cancers13194765.
5
Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy.术前血清甲胎蛋白（AFP）水平与肝癌（HCC）肝切除术后预后的相关性分析。
World J Surg Oncol. 2013 Aug 27;11:212. doi: 10.1186/1477-7819-11-212.
6
Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.尿液甲胎蛋白和血清黏蛋白 1 作为乙型肝炎病毒相关性肝细胞癌的生物标志物。
Am J Physiol Gastrointest Liver Physiol. 2020 Feb 1;318(2):G305-G312. doi: 10.1152/ajpgi.00267.2019. Epub 2019 Nov 18.
7
Changes of serum alpha-fetoprotein and alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma: prognostic significance.肝癌肝切除术后血清甲胎蛋白和甲胎蛋白-L3 的变化：预后意义。
Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):618-23. doi: 10.1016/s1499-3872(12)60234-3.
8
The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia.在印度尼西亚，甲胎蛋白血清作为肝细胞癌监测的生物标志物仍然可靠。
BMC Gastroenterol. 2020 Jul 9;20(1):215. doi: 10.1186/s12876-020-01365-1.
9
Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.甲胎蛋白阴性肝癌根治性切除术后甲胎蛋白的临床意义。
Dig Dis Sci. 2021 Dec;66(12):4545-4556. doi: 10.1007/s10620-020-06797-z. Epub 2021 Mar 16.
10
Diagnostic value of alpha-1-fetoprotein (AFP) as a biomarker for hepatocellular carcinoma recurrence after liver transplantation.α-甲胎蛋白（AFP）作为肝移植后肝细胞癌复发生物标志物的诊断价值。
Clin Biochem. 2018 Feb;52:20-25. doi: 10.1016/j.clinbiochem.2017.10.011. Epub 2017 Oct 17.
引用本文的文献
1
Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma.甲胎蛋白、磷脂酰肌醇蛋白聚糖-3和激肽原-1作为肝细胞癌诊断的生物标志物。
Int J Clin Exp Pathol. 2024 Nov 15;17(11):383-395. doi: 10.62347/QSII4050. eCollection 2024.
2
Metroticket approach in a retrospective cohort study to predict overall survival after surgical resection for hepatocellular carcinoma.在一项回顾性队列研究中采用地铁票方法预测肝细胞癌手术切除后的总生存期。
Int J Surg. 2024 Nov 1;110(11):7058-7066. doi: 10.1097/JS9.0000000000001868.
3
The role of IL-37 in gastrointestinal diseases.IL-37 在胃肠道疾病中的作用。
Front Immunol. 2024 Aug 14;15:1431495. doi: 10.3389/fimmu.2024.1431495. eCollection 2024.
4
The Performance of a Survival Nomogram and Albumin-Bilirubin Grade as Prognostic Tools in Advanced Hepatocellular Carcinoma Treated with FOLFOX4.生存列线图和白蛋白-胆红素分级作为接受FOLFOX4治疗的晚期肝细胞癌预后工具的性能
J Pers Med. 2024 Apr 11;14(4):403. doi: 10.3390/jpm14040403.
5
The role of IL-36 and 37 in hepatocellular carcinoma.白细胞介素-36和-37在肝细胞癌中的作用。
Front Immunol. 2024 Jan 19;15:1281121. doi: 10.3389/fimmu.2024.1281121. eCollection 2024.
6
Prognostic nomogram model for selecting between transarterial chemoembolization plus lenvatinib, with and without PD-1 inhibitor in unresectable hepatocellular carcinoma.不可切除肝细胞癌中经动脉化疗栓塞联合仑伐替尼，以及联合与不联合 PD-1 抑制剂的预后列线图模型。
Br J Radiol. 2024 Feb 28;97(1155):668-679. doi: 10.1093/bjr/tqae018.
7
Elevated expression patterns of P-element Induced Wimpy Testis (PIWI) transcripts are potential candidate markers for Hepatocellular Carcinoma.PIWI 转录物表达水平升高可能是肝细胞癌的潜在候选标志物。
Cancer Biomark. 2024;39(2):95-111. doi: 10.3233/CBM-230134.
8
Changes in the Epidemiology of Hepatocellular Carcinoma in Carinthia, Austria, 2012-2023.2012 - 2023年奥地利克恩顿州肝细胞癌的流行病学变化
Cancers (Basel). 2023 Oct 30;15(21):5215. doi: 10.3390/cancers15215215.
9
Recent Advances in Image-Guided Locoregional Therapies for Primary Liver Tumors.原发性肝癌图像引导下局部区域治疗的最新进展
Biology (Basel). 2023 Jul 13;12(7):999. doi: 10.3390/biology12070999.
10
Cannabis sativa demonstrates anti-hepatocellular carcinoma potentials in animal model: in silico and in vivo studies of the involvement of Akt.大麻在动物模型中显示出抗肝细胞癌的潜力：Akt参与的计算机模拟和体内研究
J Cannabis Res. 2023 Jul 12;5(1):27. doi: 10.1186/s42238-023-00190-z.
本文引用的文献
1
Prognostic value of preoperative alpha-fetoprotein (AFP) level in patients receiving curative hepatectomy- an analysis of 1,182 patients in Hong Kong.接受根治性肝切除术患者术前甲胎蛋白（AFP）水平的预后价值——对香港1182例患者的分析
Transl Gastroenterol Hepatol. 2019 Jul 11;4:52. doi: 10.21037/tgh.2019.06.07. eCollection 2019.
2
Proteomic profiling in liver cancer: another new page.肝癌中的蛋白质组学分析：新的篇章。
Transl Gastroenterol Hepatol. 2019 Jun 21;4:47. doi: 10.21037/tgh.2019.06.03. eCollection 2019.
3
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南：肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
4
Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.使用巴塞罗那临床肝癌系统的列线图为 C 期肝细胞癌患者选择治疗方案。
BMC Cancer. 2018 Mar 14;18(1):289. doi: 10.1186/s12885-018-4202-3.
5
The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution.甲胎蛋白在肝细胞癌肝移植领域日益增长的影响：一场变革的时候到了。
Transl Gastroenterol Hepatol. 2017 Sep 16;2:72. doi: 10.21037/tgh.2017.09.05. eCollection 2017.
6
The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma.甲胎蛋白（AFP）水平与肝癌患者病理分级、进展和生存的预后相关性。
Sci Rep. 2017 Oct 9;7(1):12870. doi: 10.1038/s41598-017-12834-1.
7
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.验证 AFP 模型作为预测病毒肝炎相关性肝硬化患者 HCC 复发的指标，这些患者因 HCC 已接受肝移植。
J Hepatol. 2017 Mar;66(3):552-559. doi: 10.1016/j.jhep.2016.10.038. Epub 2016 Nov 27.
8
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma.甲胎蛋白在肝细胞癌肝移植中的作用
World J Hepatol. 2016 Jul 28;8(21):881-90. doi: 10.4254/wjh.v8.i21.881.
9
Genetic profiling of hepatocellular carcinoma using next-generation sequencing.使用下一代测序技术对肝细胞癌进行基因谱分析。
J Hepatol. 2016 Nov;65(5):1031-1042. doi: 10.1016/j.jhep.2016.05.035. Epub 2016 Jun 2.
10
Summary of the British Transplantation Society UK Guidelines for Living Donor Liver Transplantation.英国移植学会英国活体供肝移植指南摘要。
Transplantation. 2016 Jun;100(6):1184-90. doi: 10.1097/TP.0000000000001128.
Zotero 插件